The combined action of IL-15 and IL-12 gene transfer can induce tumor cell rejection without T and NK cell involvement

被引:62
|
作者
Di Carlo, E
Comes, A
Basso, S
De Ambrosis, A
Meazza, R
Musiani, P
Moelling, K
Albini, A
Ferrini, S
机构
[1] Univ Chieti, Dipartimento Oncol & Neurosci, Chieti, Italy
[2] Ist Nazl Ric Canc, I-16132 Genoa, Italy
[3] Univ Genoa, Dipartimento Oncol Clin & Sperimentale, Genoa, Italy
[4] Univ Zurich, Inst Med Virol, Zurich, Switzerland
来源
JOURNAL OF IMMUNOLOGY | 2000年 / 165卷 / 06期
关键词
D O I
10.4049/jimmunol.165.6.3111
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The cooperative antitumor effects of IL-12 and IL-15 gene transfer were studied in the N592 MHC class I-negative small cell lung cancer cell line xenotransplanted in nude mice. N592 cells engineered to secrete IL-15 displayed a significantly reduced tumor growth kinetics, and a slightly reduced tumor take rate, while N592 engineered with IL-12 displayed only minor changes in their growth in nude mice. However, N592 cells producing both cytokines were completely rejected, and produced a potent local bystander effect, inducing rejection of coinjected wild-type tumor cells. N592/IL-12/IL-15 cells were completely and promptly rejected also in NK-depleted nude mice, while in granulocyte-depleted animals a slight delay in the rejection process was observed. Immunohistochemical analyses of the N592/IL-12/IL-15 tumor area in intact nude mice revealed the presence of infiltrating macrophages, granulocytes, and NK cells, and expression of inducible NO synthase and of secondary cytokines such as IL-1 beta, TNF-alpha, and IFN-gamma, and at higher levels GM-CSF, macrophage-inflammatory protein-2, and monocyte chemoattractant protein-1. In NK cell-depleted nude mice, numerous macrophages and granulocytes infiltrated the tumor, and a strong expression of macrophage-inflammatory protein-2 and inducible NO synthase was also observed. Finally, macrophages cocultured with N592/IL-12/IL-15 produced NO in vitro, and inhibited tumor cell growth, further suggesting their role as effector cells in this model.
引用
收藏
页码:3111 / 3118
页数:8
相关论文
共 50 条
  • [41] Distinct roles of IL-12 and IL-15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs
    Ferlazzo, G
    Pack, M
    Thomas, D
    Paludan, C
    Schmid, D
    Strowig, T
    Bougras, G
    Muller, WA
    Moretta, L
    Münz, C
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (47) : 16606 - 16611
  • [42] IL-12/15/18-induced cell death and mitochondrial dynamics of human NK cells
    Terren, Inigo
    Sanda, Victor
    Amarilla-Irusta, Ainhoa
    Lopez-Pardo, Ainara
    Sevilla, Arrate
    Astarloa-Pando, Gabirel
    Amo, Laura
    Zenarruzabeitia, Olatz
    Scorrano, Luca
    Borrego, Francisco
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [43] Development of Tumor Cell-Based Vaccine with IL-12 Gene Electrotransfer as Adjuvant
    Remic, Tinkara
    Sersa, Gregor
    Ursic, Katja
    Cemazar, Maja
    Kamensek, Urska
    VACCINES, 2020, 8 (01)
  • [44] Activation of human T cells with NK cell markers by staphylococcal enterotoxin A via IL-12 but not via IL-18
    Ami, K
    Ohkawa, T
    Koike, Y
    Sato, K
    Habu, Y
    Iwai, T
    Seki, S
    Hiraide, H
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2002, 128 (03): : 453 - 459
  • [45] IL-15 complexes induce NK- and T-cell responses independent of type I IFN signaling during rhinovirus infection
    Jayaraman, A.
    Jackson, D. J.
    Message, S. D.
    Pearson, R. M.
    Aniscenko, J.
    Caramori, G.
    Mallia, P.
    Papi, A.
    Shamji, B.
    Edwards, M.
    Westwick, J.
    Hansel, T.
    Stanciu, L. A.
    Johnston, S. L.
    Bartlett, N. W.
    MUCOSAL IMMUNOLOGY, 2014, 7 (05) : 1151 - 1164
  • [46] Treatment with heterodimeric IL-15 promotes effector T cell infiltration into several tumor types
    Bergarnaschi, Cristina
    Dimas, Konstantinos
    Nagy, Bethany
    Jensen, Shawn M.
    Fox, Bernard A.
    Felber, Barbara K.
    Pavlakis, George N.
    CYTOKINE, 2017, 100 : 180 - 181
  • [47] A role for endogenous IL-12 in tumor immunity: IL-12 is required for the acquisition of tumor-migratory capacity by T cells and the development of T cell-accepting capacity in tumor masses
    Uekusa, Y
    Gao, P
    Yamaguchi, N
    Tomura, M
    Mukai, T
    Nakajima, C
    Iwasaki, M
    Takeuchi, N
    Tsujimura, T
    Nakazawa, M
    Fujiwara, H
    Hamaoka, T
    JOURNAL OF LEUKOCYTE BIOLOGY, 2002, 72 (05) : 864 - 873
  • [48] IL-18 plus IL-12 decreases liver metastases through An NK cell, IFN-γ dependent mechanism and overcomes NK/T cell mediated suppression
    Subleski, A
    Back, TC
    Ortaldo, JR
    Wiltrout, RH
    JOURNAL OF IMMUNOTHERAPY, 2005, 28 (06) : 626 - 626
  • [49] IL-15 in tumor microenvironment causes rejection of large established tumors by T cells in a noncognate T cell receptor-dependent manner
    Liu, Rebecca Berlant
    Engels, Boris
    Schreiber, Karin
    Ciszewski, Cezary
    Schietinger, Andrea
    Schreiber, Hans
    Jabri, Bana
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (20) : 8158 - 8163
  • [50] Combining Deep™ IL-12 Primed and Deep™ IL-15 Primed T cells leverages complementary mechanisms to enhance anti-tumor activity
    Sackton, Katharine
    Geretti, Elena
    Cao, Pengpeng
    Carey, Shawn
    Liang, Xiaoyan
    Nardozzi, Jonathan
    Gui, Zishu
    Worthylake, Alicia
    Leary, Glenn
    Hewes, Becker
    Maniar, Tap
    Fitzgerald, Jonathan
    Rakestraw, Andy
    Sauer, Karsten
    Jones, Douglas
    Andresen, Thomas
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7